Cargando…
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
Multi-target inhibitors represent useful anticancer agents with superior therapeutic attributes. Here in, two novel series of benzimidazole-triazole hybrids were designed, synthesised as multi-target EGFR, VEGFR-2 and Topo II inhibitors, and evaluated for anticancer activity. Compounds 5a and 6g wer...
Autores principales: | Othman, Dina I. A., Hamdi, Abdelrahman, Tawfik, Samar S., Elgazar, Abdullah A., Mostafa, Amany S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858449/ https://www.ncbi.nlm.nih.gov/pubmed/36651111 http://dx.doi.org/10.1080/14756366.2023.2166037 |
Ejemplares similares
-
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
por: Al-Sanea, Mohammad M., et al.
Publicado: (2023) -
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
por: Marinescu, Maria
Publicado: (2023) -
In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
por: Tahlan, Sumit, et al.
Publicado: (2019) -
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
por: Hamdi, Abdelrahman, et al.
Publicado: (2023) -
In Vitro and In Silico Evaluations of the Antileishmanial Activities of New Benzimidazole-Triazole Derivatives
por: Eser, Mustafa, et al.
Publicado: (2023)